The effect of high-intensity interval training on cognitive function in patients with substance use disorder: Study protocol for a two-armed randomized controlled trial.
BRIEF-A
cognitive function
executive function
exercise
high-intensity interval training (HIIT)
maximal oxygen uptake
physical activity
substance use disorder (SUD)
Journal
Frontiers in sports and active living
ISSN: 2624-9367
Titre abrégé: Front Sports Act Living
Pays: Switzerland
ID NLM: 101765780
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
06
2022
accepted:
21
11
2022
entrez:
26
12
2022
pubmed:
27
12
2022
medline:
27
12
2022
Statut:
epublish
Résumé
Substance use disorder (SUD) is characterized by cognitive impairment, especially executive dysfunction. Executive function is recognized as an important determinant of treatment outcome as it is associated with dropout rate, attendance to therapy and potential relapse after treatment termination. Physical activity can have beneficial effects on cognitive function, but there is still a lack of knowledge regarding potential benefits of aerobic exercise for executive function in SUD treatment. The aim of this study is to examine the effect of aerobic high-intensity interval training (HIIT) on cognitive function and the subsequent effect on treatment outcome in patients with SUD. This study is a randomized controlled trial, including men and women ≥18 years with diagnosed SUD by ICD-10. The patients will be recruited from the department for inpatient treatment at Blue Cross - Lade Addiction Treatment Center, Trondheim, Norway. Participants will be randomized 1:1 into either HIIT (3x/week) + treatment as usual (TAU), or TAU alone. Study outcomes will be assessed at baseline, after eight weeks of intervention, and at 3- and 12-months follow-up. The primary outcome is to compare the change in executive function (via altered BRIEF-A score, Behavior Rating Inventory of Executive Function-Adult) measured between the two study groups after eight weeks. Secondary outcomes include mapping of cognitive function in different subgroups (e.g. type of substance, age, fitness level), collecting self-reported information about quality of life, craving, sleep quality, etc., as well as assessing compliance to TAU and long-term treatment outcome. The project was approved by the Regional Ethical Committee and will be performed in accordance with this protocol and the Declaration of Helsinki. Written informed consent will be obtained from all participants prior to inclusion. This project will explore a novel approach to how exercise can be applied in SUD treatment, beyond the well-known effects on physical health. We expect to achieve new knowledge in regard to what extent HIIT can improve cognitive abilities and subsequent treatment outcome in SUD. https://www.clinicaltrials.gov/NCT05324085.
Identifiants
pubmed: 36570498
doi: 10.3389/fspor.2022.954561
pmc: PMC9780390
doi:
Banques de données
ClinicalTrials.gov
['NCT05324085']
Types de publication
Journal Article
Langues
eng
Pagination
954561Informations de copyright
© 2022 Haberstroh, Weider, Flemmen, Loe, Andersson, Hallgren and Mosti.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Psychopathology. 2002 Mar-Jun;35(2-3):82-8
pubmed: 12145489
Eur J Neurol. 2005 Jun;12 Suppl 1:28-33
pubmed: 15877775
Front Psychiatry. 2019 Dec 23;10:877
pubmed: 31920740
Nord J Psychiatry. 2003;57(2):113-8
pubmed: 12745773
BMC Psychiatry. 2017 Feb 20;17(1):73
pubmed: 28219361
PLoS One. 2013;8(1):e55176
pubmed: 23372832
Front Neurosci. 2020 Jan 23;13:1455
pubmed: 32038149
J Subst Abuse Treat. 1995 Sep-Oct;12(5):327-33
pubmed: 8583515
J Sci Med Sport. 2019 May;22(5):607-610
pubmed: 30527685
Exp Brain Res. 2018 May;236(5):1421-1430
pubmed: 29536150
Biomed Res Int. 2014;2014:616935
pubmed: 24724089
Nutrients. 2019 Oct 12;11(10):
pubmed: 31614762
Br J Sports Med. 2022 Mar;56(5):279-291
pubmed: 34531186
Neuron. 2012 Dec 20;76(6):1225-37
pubmed: 23259956
J Consult Clin Psychol. 2005 Dec;73(6):1175-80
pubmed: 16392990
Exp Clin Psychopharmacol. 2009 Oct;17(5):337-44
pubmed: 19803633
Neurology. 2019 Feb 26;92(9):e905-e916
pubmed: 30700591
Complement Ther Med. 2021 May;58:102690
pubmed: 33618011
Front Psychiatry. 2018 Jul 19;9:305
pubmed: 30072923
Clin Psychol Rev. 2013 Dec;33(8):1010-24
pubmed: 24029221
J Int Neuropsychol Soc. 2006 May;12(3):405-15
pubmed: 16903133
J Clin Exp Neuropsychol. 2018 Mar;40(2):107-122
pubmed: 28436744
Int J Environ Res Public Health. 2021 Mar 30;18(7):
pubmed: 33808399
Science. 2020 Jul 10;369(6500):167-173
pubmed: 32646997
Eur J Pharmacol. 2010 Jan 10;626(1):104-12
pubmed: 19836375
Brain Behav Immun. 2011 Aug;25(6):1063-77
pubmed: 21435392
Qual Life Res. 2004 Mar;13(2):299-310
pubmed: 15085902
J Atten Disord. 2020 Jan;24(1):41-51
pubmed: 30296883
Nat Rev Endocrinol. 2012 Apr 03;8(8):457-65
pubmed: 22473333
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Physiol Behav. 2016 Mar 1;155:224-30
pubmed: 26723268
Drug Alcohol Depend. 2012 Apr 1;122(1-2):11-9
pubmed: 22209385
Nat Commun. 2017 May 23;8:15557
pubmed: 28534495
J Pers. 2004 Apr;72(2):271-324
pubmed: 15016066
Brain Res. 2012 May 9;1453:87-101
pubmed: 22480735
J Subst Abuse Treat. 2019 Feb;97:21-27
pubmed: 30577896
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Addict Behav. 2021 Feb;113:106667
pubmed: 33074123
Biol Res Nurs. 2004 Oct;6(2):151-7
pubmed: 15388912
Sleep. 2011 May 01;34(5):601-8
pubmed: 21532953
J Subst Abuse Treat. 2016 Jul;66:1-8
pubmed: 27211990
Appl Neuropsychol Child. 2013;2(2):125-32
pubmed: 23442015
PLoS One. 2014 Jan 14;9(1):e85276
pubmed: 24454832
J Affect Disord. 2021 Jan 15;279:208-216
pubmed: 33059224
Physiol Rev. 2016 Oct;96(4):1169-209
pubmed: 27489306
Behav Neurol. 2020 Feb 12;2020:7807856
pubmed: 32104516
Neurosci Biobehav Rev. 2011 Jan;35(3):377-406
pubmed: 20451551
BMC Health Serv Res. 2013 May 22;13:185
pubmed: 23692822
Perspect Psychol Sci. 2019 Sep;14(5):734-764
pubmed: 31365839
J Sports Sci. 2021 Jan;39(1):10-22
pubmed: 32780634
Int J Psychophysiol. 2021 Feb;160:10-17
pubmed: 33340560
Nat Neurosci. 2005 Nov;8(11):1458-63
pubmed: 16251988
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Sports Med (Hindawi Publ Corp). 2016;2016:3968393
pubmed: 28116349
Ageing Res Rev. 2022 Mar;75:101559
pubmed: 34999248
J Affect Disord. 2020 Feb 15;263:629-660
pubmed: 31780128
J Subst Abuse Treat. 2014 Jul;47(1):58-72
pubmed: 24629886
Psychol Addict Behav. 2006 Sep;20(3):241-53
pubmed: 16938062
Cell Metab. 2013 Nov 5;18(5):649-59
pubmed: 24120943
J Neurosci. 2001 Aug 1;21(15):5678-84
pubmed: 11466439
Addict Behav. 2019 Mar;90:222-228
pubmed: 30447514
Drug Alcohol Depend. 2015 Sep 1;154:1-13
pubmed: 26072219
J Subst Abuse Treat. 1992;9(3):199-213
pubmed: 1334156
Am J Drug Alcohol Abuse. 1994 Nov;20(4):495-515
pubmed: 7832182
Brain Sci. 2020 Feb 04;10(2):
pubmed: 32033006
Front Psychiatry. 2019 Aug 27;10:600
pubmed: 31507468
Med Sci Sports Exerc. 2019 Jun;51(6):1242-1251
pubmed: 31095081
Dement Geriatr Cogn Dis Extra. 2017 Jul 18;7(2):249-256
pubmed: 28868068
Int J Mol Sci. 2020 Aug 16;21(16):
pubmed: 32824367
J Sports Sci. 2019 Oct;37(19):2175-2183
pubmed: 31164040
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
J Neurosci. 2019 Mar 27;39(13):2369-2382
pubmed: 30692222